Royal Bank of Canada
ICCM icon

Royal Bank of Canada’s IceCure Medical ICCM Stock Holding History

Royal Bank of Canada’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$1K – 7362
2025
Q3 		$1K Hold
17
– – ﹤0.01% 6990
2025
Q2 		$0 Hold
17
– – ﹤0.01% 7164
2025
Q1 		$1K Hold
17
– – ﹤0.01% 6670
2024
Q4 		$1K Sell
17
-19
-53% -$435 ﹤0.01% 6785
2024
Q3 		$0 Hold
36
– – ﹤0.01% 7103
2024
Q2 		$1K Buy
36
+13
+57% +$414 ﹤0.01% 6828
2024
Q1 		$1K Hold
23
– – ﹤0.01% 6801
2023
Q4 		$1K Hold
23
– – ﹤0.01% 6936
2023
Q3 		$0 Hold
23
– – ﹤0.01% 7297
2023
Q2 		$1K Hold
23
– – ﹤0.01% 7013
2023
Q1 		$1K Hold
23
– – ﹤0.01% 6895
2022
Q4 		$1K Buy
23
+6
+35% +$215 ﹤0.01% 7037
2022
Q3 		$1K Sell
17
-6
-26% -$296 ﹤0.01% 7200
2022
Q2 		$1K Hold
23
– – ﹤0.01% 7133
2022
Q1 		$2K Hold
23
– – ﹤0.01% 7480
2021
Q4 		$2K Buy
23
+8
+53% +$1.34K ﹤0.01% 7404
2021
Q3 		$4K Buy
+15
New +$4.45K ﹤0.01% 7197

Other funds holding ICCM

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

Royal Bank of Canada's ICCM Position: Q4 2025 in Review

Royal Bank of Canada sold out of IceCure Medical (ICCM) in Q4 2025, closing a stake of 17 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in ICCM in Q3 2021 and held it in 17 quarters. The position peaked at $4K in Q3 2021. 18 funds tracked by Wall St. Rank hold ICCM as of Q4 2025.

  • Royal Bank of Canada reported no remaining IceCure Medical position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 17 IceCure Medical shares in Q4 2025, an estimated $1K.
  • Royal Bank of Canada first reported a position in IceCure Medical in Q3 2021 and held it in 17 quarters.
  • Royal Bank of Canada's IceCure Medical position peaked at $4K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held IceCure Medical as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.